These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Increased DNA damage in patients with chronic obstructive pulmonary disease who had once smoked or been exposed to biomass. Ceylan E; Kocyigit A; Gencer M; Aksoy N; Selek S Respir Med; 2006 Jul; 100(7):1270-6. PubMed ID: 16307872 [TBL] [Abstract][Full Text] [Related]
5. Trace elements and oxidative stress in chronic obstructive pulmonary disease. Isik B; Isik RS; Ceylan A; Calik O Saudi Med J; 2005 Dec; 26(12):1882-5. PubMed ID: 16380766 [TBL] [Abstract][Full Text] [Related]
6. Rethinking chronic obstructive pulmonary disease. Tonello A; Poli G Med Hypotheses; 2011 Mar; 76(3):358-60. PubMed ID: 21075542 [TBL] [Abstract][Full Text] [Related]
7. Current perspectives of oxidative stress and its measurement in chronic obstructive pulmonary disease. Lin JL; Thomas PS COPD; 2010 Aug; 7(4):291-306. PubMed ID: 20673039 [TBL] [Abstract][Full Text] [Related]
10. Association between cytochrome P450 3A5 polymorphism and the lung function in Saskatchewan grain workers. Seo T; Pahwa P; McDuffie HH; Yurube K; Egoshi M; Umemoto Y; Ghosh S; Fukushima Y; Nakagawa K Pharmacogenet Genomics; 2008 Jun; 18(6):487-93. PubMed ID: 18496128 [TBL] [Abstract][Full Text] [Related]
11. Oxidative stress in pathogenesis of chronic obstructive pulmonary disease: cellular and molecular mechanisms. Rahman I Cell Biochem Biophys; 2005; 43(1):167-88. PubMed ID: 16043892 [TBL] [Abstract][Full Text] [Related]
12. Laboratory markers for COPD in "susceptible" smokers. Tzortzaki EG; Tsoumakidou M; Makris D; Siafakas NM Clin Chim Acta; 2006 Feb; 364(1-2):124-38. PubMed ID: 16139829 [TBL] [Abstract][Full Text] [Related]
13. Genetic polymorphism of GSTT1 and GSTM1 and susceptibility to chronic obstructive pulmonary disease (COPD). Faramawy MM; Mohammed TO; Hossaini AM; Kashem RA; Abu Rahma RM J Crit Care; 2009 Sep; 24(3):e7-10. PubMed ID: 19664521 [TBL] [Abstract][Full Text] [Related]
14. [The study of interleukin-13 gene promoter polymorphism in patients with chronic obstructive pulmonary disease]. He B; Zhao MW; Ning LD; Jiang L; Yao WZ Zhonghua Jie He He Hu Xi Za Zhi; 2004 Aug; 27(8):529-32. PubMed ID: 15388001 [TBL] [Abstract][Full Text] [Related]
15. Genetic polymorphisms of GSTP1 and mEPHX correlate with oxidative stress markers and lung function in COPD. Vibhuti A; Arif E; Deepak D; Singh B; Qadar Pasha MA Biochem Biophys Res Commun; 2007 Jul; 359(1):136-42. PubMed ID: 17532303 [TBL] [Abstract][Full Text] [Related]
18. [Effects of smoking on the pathogenesis of COPD]. Tatsumi K Nihon Rinsho; 2007 Apr; 65(4):605-10. PubMed ID: 17419375 [TBL] [Abstract][Full Text] [Related]
19. Aspects on pathophysiological mechanisms in COPD. Larsson K J Intern Med; 2007 Sep; 262(3):311-40. PubMed ID: 17697154 [TBL] [Abstract][Full Text] [Related]